second-line

Review of Current and Upcoming Second-Line Treatments for Primary Biliary Cholangitis

Cumpian NA, Choi G, Saab S. Review of Current and Upcoming Second-Line Treatments for Primary Biliary Cholangitis. Dig Dis Sci. 2024 Dec 2. doi: 10.1007/s10620-024-08742-w.[...]

By sjmartinez • December 2, 2024

Ramucirumab plus FOLFIRI or irinotecan as second-line treatment for patients with gastroesophageal adenocarcinoma: a review and meta-analysis of an emerging option

Park H, Klempner SJ, Chao J, Wainberg ZA, Lukanowski M, Chenji S, Bourke S, Chatterjee A, Lorenzen S. Ramucirumab plus FOLFIRI or irinotecan as second-line[...]

By sjmartinez • September 1, 2024